Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Livingston

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Science (New York, N.Y.)|May 2, 2009
Cancer. Complicated supercomplexesDavid M Livingston
Nature Medicine|February 5, 2004
EMSY, a BRCA-2 partner in crimeDavid M Livingston
Cancer Cell|February 13, 2020
Opening a Door to PARP Inhibitor-Induced Lethality in HR-Proficient Human Tumor CellsElodie Hatchi, David M Livingston
Virology|January 13, 2009
Small DNA tumor viruses: large contributors to biomedical sciencesPeter M Howley, David M Livingston
Nature Cell Biology|April 2, 2005
Promoter usage of BRCA1-IRISWael M Elshamy, David M Livingston
Nature Cell Biology|September 28, 2004
Identification of BRCA1-IRIS, a BRCA1 locus productWael M ElShamy, David M Livingston
Cancer Discovery|July 31, 2012
Mechanisms of BRCA1 tumor suppressionDaniel P Silver, David M Livingston
Nature|February 29, 2008
Cancer: crossing over to drug resistanceDavid M Livingston, Daniel P Silver
Carcinogenesis|April 20, 2010
BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repairPeter J O'Donovan, David M Livingston
Cancer Research|December 17, 2010
Twenty-second annual Pezcoller Symposium: RNA biology and cancerRené Bernards, Witold Filipowicz, David M Livingston, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Science (New York, N.Y.)|May 2, 2009
Cancer. Complicated supercomplexesDavid M Livingston
Nature Medicine|February 5, 2004
EMSY, a BRCA-2 partner in crimeDavid M Livingston
Cancer Cell|February 13, 2020
Opening a Door to PARP Inhibitor-Induced Lethality in HR-Proficient Human Tumor CellsElodie Hatchi, David M Livingston
Virology|January 13, 2009
Small DNA tumor viruses: large contributors to biomedical sciencesPeter M Howley, David M Livingston
Nature Cell Biology|April 2, 2005
Promoter usage of BRCA1-IRISWael M Elshamy, David M Livingston
Nature Cell Biology|September 28, 2004
Identification of BRCA1-IRIS, a BRCA1 locus productWael M ElShamy, David M Livingston
Cancer Discovery|July 31, 2012
Mechanisms of BRCA1 tumor suppressionDaniel P Silver, David M Livingston
Nature|February 29, 2008
Cancer: crossing over to drug resistanceDavid M Livingston, Daniel P Silver
Carcinogenesis|April 20, 2010
BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repairPeter J O'Donovan, David M Livingston
Cancer Research|December 17, 2010
Twenty-second annual Pezcoller Symposium: RNA biology and cancerRené Bernards, Witold Filipowicz, David M Livingston, et al.
Pageof 8